REVOLUTIONIZING
THE PHARMA COLD CHAIN
CryozenicTM preserves and transports pharmaceutical products at optimum temperatures with no functional loss to product quality and efficacy.
THE PROBLEM
The pharmaceutical industry is facing several issues. Products such as vaccines and other biologicals require different temperatures to be preserved.
The existing cold chain can be limited to as low as -20⁰C, while some products, like certain brands of the new COVID-19 vaccine, require an extremely low temperature of -70⁰C to be preserved. Any slight alteration in temperature may render the product ineffective. High energy, maintenance, and transportation costs are additional problems
OUR SOLUTION
CryozenicTM to the rescue.
With our patented and proprietary technologies, we can ensure long-haul transport of biologicals at extremely low temperatures (as low as -70 °C), at lesser than 50% costs, without any quality or functional loss to the product. Our Active Insulation process allows us to store products at the required temperature using green energy, thereby reducing maintenance, logistics, and energy costs.
HOW DOES THIS WORKS ?
The CryozenicTM Gel cross-linked polymers are specifically designed to preset required temperature for requisite duration.
Our specialized procedure then controls the process to ensure that the products are Super-FreshedTM to usable temperatures with minimum quality or functional loss. Active Insulation process ensures transport of all temperature sensitive materials at their optimum temperatures, without any fluctuation, or need for special logistics, hence being a cost effective yet flexible way of maintaining perishables at a fixed temperature for extended time periods.